Intravenous immunoglobulin for the treatment of Kawasaki disease in children - Wikidata - wikimedia - TriplyDB

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

http://www.wikidata.org/entity/Q24247776

about

Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers Steroid hormone treatment for Kawasaki disease in children Corticosteroids for the treatment of Kawasaki disease in children Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers Steroid hormone treatment for Kawasaki disease in children Salicylate for the treatment of Kawasaki disease in children Acute Kawasaki disease: not just for kids Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome Kawasaki Disease: A Clinician's Update Use of intravenous immunoglobulin in pediatric practice Intravenous immunoglobulin as clinical immune-modulating therapy.Recognising Kawasaki disease in UK primary care: a descriptive study using the Clinical Practice Research Datalink.Advances in the use of biologic agents for the treatment of systemic vasculitis Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia.Indications for IVIG in rheumatic diseases Intravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa.Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study Kawasaki disease (syndrome)-our experience-Corticosteroids for the treatment of Kawasaki disease in children.Clinical uses of intravenous immunoglobulin.Epidemiologic survey of Kawasaki disease in Inner Mongolia, China, between 2001 and 2013.Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.Potential and Limitations of Cochrane Reviews in Pediatric Cardiology: A Systematic Analysis.Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study.Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.Kawasaki disease: always straight to the heart?Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.Prediction of resistance to standard intravenous immunoglobulin therapy in kawasaki disease.Recommendations for the use of albumin and immunoglobulins.Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).TNF-α blockers for the treatment of Kawasaki disease in children

P2860

Q24186274-09E208EA-1652-4A27-9E64-BF2A42574C22 Q24194442-5D6213DF-7C1D-4C0B-BE5F-2BEBAA8FF906 Q24194653-CB2B9DE6-5012-484B-82C8-4A063B1C73A4 Q24236448-C6C1FA89-CEBB-457D-A60C-674E0270BFA4 Q24242875-48FC637A-AC37-4000-AF11-7FFE79FFFCA8 Q24243818-67F9EA69-C482-4578-9057-C6575394F2E1 Q24682484-53FFFB6D-270F-4393-96BC-9C41C398AF54 Q26765479-B26E7D3A-042D-4025-8E81-04E6DA328398 Q26998791-CE5D98DC-FDB5-4A28-AD01-889A28F9B95A Q27011481-1DDBC2B7-91C2-4309-8060-FB25D2D707A6 Q33420267-01996C58-1181-4AC5-988D-8ED2037C2065 Q33951717-3B84B5AB-C5E8-4398-8188-D733FC941F57 Q34065598-4E217EE5-D578-4939-B374-56EEE63B9530 Q34844126-060B3AF8-617E-4056-B103-6271381C07F7 Q35102141-04BB8912-428F-4E01-8B6A-582ACCA02113 Q35309185-4EAFB96D-CEC9-4206-8453-79AE5FCB5D23 Q36015444-0DDD4720-B0E6-4E90-ACE9-9CBE10BC3E1D Q36106176-6929D754-7A37-4308-A8D3-571682DE85D9 Q36246685-165E91AA-B139-4654-AF6A-609AA323EE22 Q36259694-13C82004-4E4B-4DB7-B413-21270812A4F8 Q36262749-6BB8B9A9-F64F-4AB8-A975-38C8F0CCD0BD Q36264883-7BD61D0D-9771-4243-BF6B-CAE192BE0FA7 Q37108769-53821913-29CB-411A-8C33-80402D8ED067 Q37626123-E91BBB4A-AE25-4EC6-A102-20B9557201EE Q38940637-F0DF46BF-185C-43DD-A605-82913A799CAA Q39016381-3D847E3C-ABD9-497B-B781-DE36B28F2F67 Q40275624-333836E8-8834-4A2D-A4D6-BEE241DD191E Q40276542-044054D5-0236-40A3-8C7F-551DFE2C180A Q41546604-F4B8E2A8-D199-492D-931A-CD1A2B9141E6 Q41733404-E6583F94-551C-44D8-9133-CD24615AB3DB Q42671923-2E77F3DB-5426-4DD0-B621-CC116A83871E Q54144614-30E9402C-E736-45AA-A467-7D4F10AF658B Q56759657-5096D37C-B572-49C9-810F-35DB46C85861

P2860

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

http://www.wikidata.org/entity/Q24247776

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@ast

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@en

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@en-gb

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@nl

type

label

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@ast

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@en

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@en-gb

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@nl

prefLabel

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@ast

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@en

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@en-gb

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@nl

P1433

Q24247776-A814458B-9D28-479A-BB54-B5291E8D7D94

P1476

Q24247776-BCAF4130-E748-4180-B122-556ACA5BD34F

P2093

Q24247776-107E5C34-C560-4D55-828A-969AF8DDA319

Q24247776-1E9B81A9-42BE-46C5-B909-9FCD555CA3B9

Q24247776-36E3ABE1-4626-4372-A929-17BFB313A97D

Q24247776-85E37A15-A9AE-4755-88AE-4ED62AF968AD

Q24247776-AFE46069-9F89-4684-9629-0819396A5AAF

Q24247776-D086B998-69BA-4612-ACA1-0E74DF32AE9A

Q24247776-EE1AB949-1EC0-4D50-9383-9EDC8CB9B057

Q24247776-FDFEC954-3144-4924-ADF2-6CBF155A8261

P2860

Q24247776-05298318-B230-4232-996C-4F3C56EF23C9

Q24247776-0602B5DA-E289-497D-B6CD-A23CB8920ABD

Q24247776-15E38783-E5FE-4F75-98B2-696B7EB7CFC9

Q24247776-1860E4A3-D4AC-4D89-8977-6520D9774F16

Q24247776-1A147E1A-0407-4BD8-9396-0EDDB649DF13

Q24247776-1CB21577-59F1-4AA1-9AD9-C6D5CC56CB82

Q24247776-25B5827D-61FC-42EC-93D4-09C85A96C1EF

Q24247776-401DB430-C2B3-4AAC-9725-EE77CE4E4A23

Q24247776-4F166D74-44C2-426D-A12C-7A19237A6778

Q24247776-5E7DE83A-EDEF-4CE3-AFFF-4EBCBA326A97

P304

Q24247776-1ECEC406-5BB9-429C-B38D-FA53EFA55ADF

P31

Q24247776-11ff67b1-bae9-43f1-81f9-7b2c7b547f44

Q24247776-B513E6E3-B23E-46DA-B800-8BAB73D1D091

P3181

Q24247776-CB4F572C-D08B-4EB8-9ECC-28019AC048E6

P356

Q24247776-D26FE67F-286B-4750-AEF1-78CD7497B943

P433

Q24247776-4C43ADE3-9098-46C5-A725-1ED6618EB3AC

P50

Q24247776-C34F4030-5FFC-4D1B-AA98-099974174250

P577

Q24247776-A38790CB-7806-40DA-A23B-C84E5D7DA399

P698

Q24247776-1109BC72-5240-4061-AC51-D5F2AF6C4537

P932

Q24247776-2FFAE9CB-0C6B-4E49-93A6-7F781C7B256F

P3181

P356

14651858.CD004000

P1433

Cochrane Database of Systematic Reviews

P1476

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

@en

P2093

A Gupta

http://www.w3.org/2001/XMLSchema#string

I Flynn

http://www.w3.org/2001/XMLSchema#string

J H Baumer

http://www.w3.org/2001/XMLSchema#string

J S Dua

http://www.w3.org/2001/XMLSchema#string

K Roman

http://www.w3.org/2001/XMLSchema#string

L Haines

http://www.w3.org/2001/XMLSchema#string

R M Oates-Whitehead

http://www.w3.org/2001/XMLSchema#string

S Love

http://www.w3.org/2001/XMLSchema#string

P2860

Salicylate for treatment of Kawasaki disease in children

Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research

Early treatment with intravenous immunoglobulin in patients with Kawasaki disease

Rising incidence of Kawasaki disease in England: analysis of hospital admission data.

Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria.

Management of Kawasaki disease in the British Isles.

Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.

Incomplete Kawasaki disease with coronary artery involvement.

Diagnosis and therapy of Kawasaki disease in children.

A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

P304

CD004000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1694692

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD004000

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14584002

http://www.w3.org/2001/XMLSchema#string

P932

6544780

http://www.w3.org/2001/XMLSchema#string